| Name | [4-amino-2-(trifluoromethyl)phenyl]-(4-methylpiperazin-1-yl)methanone |
|---|---|
| Synonyms |
[4-Amino-2-(trifluoromethyl)phenyl](4-methyl-1-piperazinyl)methanone
4-[(4-methylpiperazin-1-yl)carbonyl]-3-(trifluoro-methyl)aniline (4-amino-2-trifluoromethyl-phenyl)-(4-methylpiperazin-1-yl)-methanone Piperazine,1-[4-amino-2-(trifluoromethyl)benzoyl]-4-methyl |
| Molecular Formula | C13H16F3N3O |
|---|---|
| Molecular Weight | 287.28100 |
| Exact Mass | 287.12500 |
| PSA | 49.57000 |
| LogP | 2.13220 |
| HS Code | 2933599090 |
|---|
|
~%
853297-04-8 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2005/51366 A2, 2005 ; Location in patent: Page/Page column 61 ; WO 2005/051366 A2 |
| Precursor 1 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |